Skip to content

Observational study of preventive effects of locomotive syndrome by treating osteoporosis

Observational study of preventive effects of locomotive syndrome by treating osteoporosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-jRCT1040210025
Enrollment
120
Registered
2021-05-27
Start date
2021-05-27
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary osteoporosis Osteoporosis

Interventions

None listed

Sponsors

Sobue Naohisa
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Postmenopausal women with osteoporosis 2. Patients who used bisphosphonate and were given the pamphlet of exercise (locomotion training) 3. Written informed consent

Exclusion criteria

Exclusion criteria: 1. Previous romosozumab or denosumab or teriparatide or bisphosphonate use 2. Hypocalcemia 3. Patients judged to be in appropriate for study

Design outcomes

Primary

MeasureTime frame
Relationship between changes in the 25-question Geriatric Locomotive Function Scale and changes in bone density

Secondary

MeasureTime frame
1. Relationship between changes in the 25-question Geriatric Locomotive Function Scale and each factor (age, BMI, mean daily step count, grip strength, presence of osteoarthritis or low back pain or knee pain, whether locomotion training was practiced, TRACP-5b, P1NP) 2. (Target: Patients whose baseline is not locomotive syndrome) Relationship between whether they became locomotive syndrome in an year and each factor

Contacts

Public ContactYasumori Sobue

Sobue Orthopedic Clinic, Japanese Red Cross Nagoya Daiichi Hospital

yasumorisobue527@yahoo.co.jp+81-567-67-5010

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026